Name: Managing Discovery in the Life Sciences: Harnessing Creativity to Drive Biomedical Innovation (en Inglés)
Price: 104.68 USD
Availability: InStock
Author: Rea, Philip A. ; Pauly, Mark V. ; Burns, Lawton R.
ISBN: 9781107130906

portada Managing Discovery in the Life Sciences: Harnessing Creativity to Drive Biomedical Innovation (en Inglés)

Formato

Libro Físico

Autor

Lawton R. Burns

Mark V. Pauly

Philip A. Rea

Editorial

Cambridge University Press

Año

2018

Idioma

Inglés

N° páginas

554

Encuadernación

Tapa Dura

Dimensiones

24.2 x 21.7 x 3.0 cm

Peso

1.01 kg.

ISBN13

9781107130906

Categorías

Las políticas del gobierno central
Economía política
Investigación médica

Managing Discovery in the Life Sciences: Harnessing Creativity to Drive Biomedical Innovation (en Inglés)

Lawton R. Burns (Autor) · Mark V. Pauly (Autor) · Philip A. Rea (Autor) · Cambridge University Press · Tapa Dura

Libro Físico

$ 104.68

$ 117.00

Ahorras: $ 12.32

11% descuento

Envío Express Gratis

Se enviará desde nuestra bodega entre el Lunes 29 de Abril y el Martes 30 de Abril.

Lo recibirás en cualquier lugar de Estados Unidos entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Managing Discovery in the Life Sciences: Harnessing Creativity to Drive Biomedical Innovation (en Inglés)"

In this book, distinguished scholars Philip A. Rea, Mark V. Pauly, and Lawton R. Burns explore the science and management behind marketable biomedical innovations. They look at how the science actually played out through the interplay of personalities, the cultures within and between academic and corporate entities, and the significance of serendipity not as a mysterious phenomenon but one intrinsic to the successes and failures of the experimental approach. With newly aggregated data and case studies, they consider the fundamental economic underpinnings of investor-driven discovery management, not as an obstacle or deficiency as its critics would contend or as something beyond reproach as some of its proponents might claim, but as the only means by which scientists and managers can navigate the unknowable to discover new products and decide how to sell them so as to maximize the likelihood of establishing a sustainable pipeline for still more marketable biomedical innovations.